ARDAN PHARMA is a discovery-stage company developing drugs to stimulate immune responses against cancer. Our scientific team has over ten years of exhaustive study upon immune system modulation, harnessing the power of inflammasome among cancer breakthrough therapies. Our technology targets emerging molecular pathways leading to the creation of a first-in-class portfolio for unmet medical needs in oncology.